Marlinz Pharma was awarded the patent for a “Method for treating fungal infections in nails” which focuses on the stabilization of the formula and its ability to penetrate into nails. The patent was originally filed August 8, 2017. This is a significant milestone recognizing the revolutionary ideas and research that led to the success of the Tolcylen Antifungal/Nail Renewal Solution. There are an additional 4 patents pending for the formulation.
Marlinz Pharma is Awarded Patent for Tolcylen Solution
